AMENDMENT TO SEED CAPITAL ACCELERATOR LOAN AGREEMENT AND SEED CAPITAL LOAN NOTESeed Capital Accelerator Loan Agreement • May 14th, 2019 • Sun BioPharma, Inc. • Pharmaceutical preparations • Florida
This Amendment to Seed Capital Acceleration Loan Agreement and Seed Capital Loan Note (this “Amendment”) is made and entered into as of the date below and effective as of October 26, 2017 (the “Effective Date”) by and between Sun BioPharma, Inc., a Delaware corporation (“Maker”) and Institute for Commercialization of Public Research, Inc. (“Lender”).
THIRD AMENDMENT TO SEED CAPITAL ACCELERATOR LOAN AGREEMENT AND SEED CAPITAL LOAN NOTESeed Capital Accelerator Loan Agreement • March 24th, 2020 • Sun BioPharma, Inc. • Pharmaceutical preparations • Florida
This Third Amendment to Seed Capital Acceleration Loan Agreement and Seed Capital Loan Note (this “Amendment”) is made and entered into as of the date below and effective as of December 16, 2019 (the “Effective Date”) by and between Sun BioPharma, Inc., a Delaware corporation (“Maker”) and Institute for Commercialization of Public Research, Inc. now known as Institute for Commercialization of Florida Technology, Inc. and its wholly owned subsidiary, Florida Technology Seed Capital Fund, LLC (“Lender”).
SECOND AMENDMENT TO SEED CAPITAL ACCELERATOR LOAN AGREEMENT AND SEED CAPITAL LOAN NOTESeed Capital Accelerator Loan Agreement • May 14th, 2019 • Sun BioPharma, Inc. • Pharmaceutical preparations • Florida
This Amendment to Seed Capital Acceleration Loan Agreement and Seed Capital Loan Note (this “Second Amendment”) is made and entered into as of the date below and effective as of May 1, 2019 (the “Effective Date”) by and between Sun BioPharma, Inc., a Delaware corporation (“Maker”) and Institute for Commercialization of Public Research, Inc. now known as Institute for Commercialization of Florida Technology, Inc. and its wholly owned subsidiary, Florida Technology Seed Capital Fund, LLC (“Lender”).
